Plaza de Cibeles, Madrid

In our latest ESMO preview series, we selected a modality to focus on and explore the potential opportunities and challenges many will face in the clinic.

There are a number of issues to address in this space:

  • Will new developments in technical design features help us see more agents over the finish line or are they doomed to repeat the mistakes of past?
  • As we see a much broader range of targets being evaluated, will this help or hinder the process?
  • What factors need to see improvement if we want to increase the number of Health Authority approvals?

There is no doubt the face of oncology R&D is changing – will recent successes help others over the line as well?  To find out, we looked a large number of abstracts and selected some for discussion.

Here are our insights on the current state of play…

To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by